Replies to post #141270 on Biotech Values

[DewDiligence]

Does MNTA pay a fixed fee/royalty to Eli Lilly for use of Gemzar with M402?

There is no royalty payable to LLY, and MNTA does not even need permission from LLY to use Gemzar (or a generic equivalent) in the M402 clinical trial. MNTA simply buys the drug through ordinary commercial channels.